Neglected Diseases - New Compounds and Treatments

Author(s): Luciana Scotti*, Marcus T. Scotti

Journal Name: Current Medicinal Chemistry

Volume 27 , Issue 5 , 2020

Become EABM
Become Reviewer
Call for Editor

Scotti, L.; Mendonca, F.J.B.; Moura, R.O.; Ribeiro, F.F.; Ishiki, H.; Da Silva, M.; Filho, J.M.B.; Scotti, M.T. Multi-target drugs for neglected diseases. Curr. Pharm. Des., 2016, 22(21), 3135-3163.
[] [PMID: 26907943]
Kindhauser, M.K. World Health Organization.. Communicable diseases 2002:Global defence against the infectious disease threat; Geneva, 2003.
Hunt, P. WHO. Neglected diseases: a human rights analysis, TDR/STR/SEB/ST/07.2. 2007.
Ribeiro, F.F.; Junior, F.; da Silva, M.S.; Scotti, M.T.; Scotti, L. Computational and investigative study of flavonoids active against Trypanosoma cruzi and Leishmania spp. Nat. Prod. Commun., 2015, 10(6), 917-920.
[] [PMID: 26197515]
Scotti, L.; Ishiki, H.; Mendonca, F.J.B.; Da Silva, M.S.; Scotti, M.T. In-silico analyses of natural products on Leishmania enzyme targets. Mini Rev. Med. Chem., 2015, 15(3), 253-269.
[] [PMID: 25769973]
Gilbert, I.H. Drug discovery for neglected diseases: molecular target-based and phenotypic approaches miniperspectives series on phenotypic screening for antiinfective targets. J. Med. Chem., 2013, 56(20), 7719-7726.
[] [PMID: 24015767]
Scotti, L.; Mendonca, F.J.B.; Moreira, D.R.; Mp; da Silva, M.S.; Pitta, I.R.; Scotti, M.T. SAR, QSAR and docking of anticancer flavonoids and variants: a review. Curr. Top. Med. Chem., 2012, 12(24), 2785-2809.
[] [PMID: 23368103]
Scotti, L.; Scotti, M.T.; Pasqualoto, K.F.M.; Bolzani, V.D.; Ferreira, E.I. Molecular physicochemical parameters predicting antioxidant activity of Brazilian natural products. Rev. Bras. Farmacogn., 2009, 19(4), 908-913.
Bellera, C.L.; Alberca, L.N.; Sbaraglini, M.L.; Talevi, A. In Silico drug repositioning for chagas disease. Curr. Med. Chem., 2020, 27(5), 662-675.
[] [PMID: 31622200]
Thomas, C.M.; Timson, D.J. The mechanism of action of praziquantel: can new drugs exploit similar mechanisms? Curr. Med. Chem., 2020, 27(5), 676-696.
[] [PMID: 30259811]
Halder, A.K.; Cordeiro, M.N.D.S. Advanced in silico methods for the development of anti-leishmaniasis and anti-trypanosomiasis agents. Curr. Med. Chem., 2020, 27(5), 697-718.
[] [PMID: 30378482]
Hosseini, S.; Munoz-Soto, R.B.; Oliva-Ramirez, J.; Vazquez-Villegas, P.; Aghamohammadi, N.; Rodriguez-Garcia, A.; Martinez-Chapa, S.O. Latest updates in dengue fever therapeutics: natural, marine and synthetic drugs. Curr. Med. Chem., 2020, 27(5), 719-744.
[] [PMID: 2995661]
de Ávila, M.B.; Bitencourt-Ferreira, G.; de Azevedo, Jr. W.F. Structural basis for inhibition of enoyl-[acyl carrier protein]reductase (InhA) from Mycobacterium tuberculosis. Curr. Med. Chem., 2020, 27(5), 745-759.
[] [PMID: 30501592]
Melo, R.; Lemos, A.; Preto, A.J.; Bueschell, B.; Matos-Filipe, P.; Barreto, C.; Almeida, J.G.; Silva, R.D.M.; Correia, J.D.G.; Moreira, I. An overview of antiretroviral agents for treating HIV infection in pediatric population. Curr. Med. Chem., 2020, 27(5), 760-794.
[] [PMID: 30182840]
Scotti, M.T.; Monteiro, A.F.M.; de Oliveira Viana, J.; Junior, F.J.B., ; Ishiki, H.M.; Tchouboun, E.N.; de Araújo, R.S.A.; Scotti, L. Recent theoretical studies concerning important tropical infections. Curr. Med. Chem., 2020, 27(5), 795-834.
[] [PMID: 31296154]

free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 15 March, 2020
Page: [659 - 661]
Pages: 3
DOI: 10.2174/092986732705200316141940

Article Metrics

PDF: 25